Merck & Co. Inc. (MRK) Social Stream
Merck & Co Inc (MRK) Price Targets From Analysts
Use the tables below to see what analysts covering Merck & Co Inc think about its future price and what recommendations they have for investors and traders.
| Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|
| 17 | $110 | $70 | $90.875 | $81.67 | 11.27% |
| 14 | $110 | $79 | $93.692 | $81.67 | 14.72% |
| 15 | $110 | $79 | $93.692 | $81.67 | 14.72% |
| 16 | $110 | $79 | $93.428 | $81.67 | 14.4% |
| 17 | $110 | $79 | $93.428 | $81.67 | 14.4% |
| 17 | $110 | $76 | $92.266 | $81.67 | 12.97% |
| 13 | $110 | $79 | $95.272 | $81.67 | 16.65% |
| 12 | $110 | $79 | $95.272 | $81.67 | 16.65% |
| 13 | $110 | $79 | $94.916 | $81.67 | 16.22% |
| 13 | $110 | $79 | $95.166 | $81.67 | 16.53% |
| 14 | $110 | $79 | $94.384 | $81.67 | 15.57% |
The Trend in the Analyst Price Target
MRK's average price target has moved down $5.22 over the prior 40 weeks.
MRK reports an average of 23.3% for its upside potential over the past 19 months.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-01-05 | 17 | 110 | 70 | 90.875 | 78.88 | 15.21% |
| 2020-06-10 | 18 | 107 | 84 | 93.270 | NA | NA% |
MRK Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.06 | 8 | 0 | 9 | 0 | 0 | 17 |
The Trend in the Broker Recommendations
MRK's average broker recommendation rating worsened by 0.1 over the prior 35 weeks.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- Merck & Co Inc's number of analysts covering the stock is higher than 1020.39% of Pharmaceutical Products stocks.
- In the context of Pharmaceutical Products stocks, Merck & Co Inc's upside potential (average analyst target price relative to current price) is higher than 87.47% of them.
- MRK has a greater average analyst price target than 956.3% of Pharmaceutical Products stocks.
- MRK has a lower variance in analysts' estimates than -254.63% of Pharmaceutical Products stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Merck & Co Inc are SGEN, GILD and PFE.
Is MRK a Buy, Hold or Sell? See the POWR Ratings now!